Director, US Medical Affairs (US DMA) - Pulmonary Hypertension

Role Summary The US Director of Medical Affairs (US DMA), Pulmonary Hypertension, is a regionally based position within our Research & Development Division, US Medical Affairs (USMA). This position strategically drives scientific excellence across in-line business and the One Pipeline while optimizing field readiness across the USMA strategic pillars: 1.) Scientific Exchange 2.) Company Trials 3.) Investigator-Sponsored Programs 4.) Congresses 5.) Insights The US DMA is an experienced therapeutic area (TA) leader and subject matter expert (SME) with relevant medical affairs and field medical experience. This role is also responsible for driving execution of scientific and medical affairs plans for assigned Therapy Areas within their region, engaging with regional cross-functional teams, and providing US input to the relevant cross-functional team meetings, e.g., US MAT, PAT, MT and V&I Plans. As a core member (or co-lead) of the US Medical Affairs Team (MAT), the US DMA collaborates with the Global TA team and cross-functional partners to enable US regional implementation of Value & Implementation (V&I) Planning by: 1) Integrating local insights into Global Scientific Value Content (GSVC) and Center of Scientific Exchange Excellence (CSEE) plans 2) Facilitating local adoption of GSVC and CSEE initiatives 3) Leading development and execution of aligned local training programs 4) Evaluating training effectiveness and application in the field.

In collaboration with USMA Executive Director (ED) and Health Systems PASL, conduct development and implementation of regional strategies aligned with headquarters V&I goals including defining a prioritized USMA Field strategy and implementation goals. Contribute to the integrated US Country Medical Affairs Plan (CMAP), including the US Field Medical Plan (FMP)/Field Engagement Plan (FEP) and field training plan for Pulmonary Hypertension as a member of the USMA Pulmonary Hypertension Leadership Team Identifies and prioritizes US field resources, training needs and activities; and in collaboration with GMVC, ensures strategically aligned content and training and any other needed adult learning activities across the portfolio. This would also include the pull-through of pre- and post-congress regional training and content. Develop a strategic and comprehensive scientific engagement plan and ensure scientific exchange aligns with the global scientific communications platform. Ensure insights from advisory boards and field medical activities are actioned with relevant stakeholders, aligned with Country Medical Affairs priorities, and monitored for trends impacting future strategy. In collaboration with relevant USMA stakeholders (e.g. HS PASL), organize expert input events (e.g., advisory boards, forums) with contracted Scientific Leaders and key stakeholders to address new indication implementation and/or emerging science. Manage programs (i.e. patient support, education, risk management) as needed for appropriate and safe utilization of company medicines. Partner with GSVC, CSEE, US Global Clinical Trial Organization (GCTO), Global Medical and Scientific Affairs (GMSA) Pulmonary Hypertension leads, and internal/external SMEs to orchestrate and deliver regional training as needed. Participate in bi-directional information exchange and sharing of best practices across USMA roles and teams, including Health Systems. Collaborate with the USMA Director of Implementation and Strategic Execution (DISE) to ensure consistent standards, processes, and harmonization for training activities (e.g., clinical immersions, verbalizations, journal clubs). Provide input into strategic congress priorities and participate in planning at key scientific congresses. Continuously monitor healthcare environment and emerging trends to optimize CMAPs and field execution plans. Additional Responsibilities Serve as a point of contact for development and maintenance of US new-hire